Medisys, Roche Settle Patent Row Over Diabetics Device

Law360, New York (February 3, 2006, 12:00 AM EST) -- The U.S. arm of British diagnostics and medical products group Medisys has resolved its longstanding patent row with Swiss rival Roche Diagnostics Corp. over blood glucose monitors used by diabetics.

Hypoguard USA Inc., the operator of Medisys’ U.S. blood glucose monitoring business, has settled a patent case that Roche brought against it and three other companies in 2004. The firm has said the undisclosed settlement is favorable to all parties.

The complaint, filed in the U.S. District Court for the Southern District of Indiana,

alleged that...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.